1. Abstract
Introduction There are few sources of empirical social contact data from resource-poor settings thus limiting the development of contextual mathematical models of disease transmission and control.
Methods We collected and analyzed cross-sectional survey data from rural and urban sites in Mozambique. Participants, including infants, were recruited. They reported retrospectively, in a paper diary, individuals with whom they had a co-located physical or conversation contact, as well as their age, sex, relationship, frequency, and duration of the contact. We compared vaccine effects (VE) by parameterizing transmission models using empirical and synthetic contact rates.
Results 1363 participants recruited between April 2021 and April 2022 reported a mean of 8.3 (95% CI 8.0–8.6) contacts per person on day 1. Mean contact rates were higher in the rural compared to urban site (9.8 [9.4–10.2 vs 6.8 [6.5–7.1], p<0.01), respectively. Participants aged ≤18 years were the main drivers of higher physical contacts. In the model, we report higher VE in the rural site when comparing empirical to synthetic contact matrices (32% vs 29%, respectively), and lower corresponding VE in urban site (32% vs 35%). These effects were prominent in the younger (0-9 years old) and older (60+ years) individuals.
Conclusion Our work suggests differences in contact rates and patterns between rural and urban sites in Mozambique, with corresponding differences in vaccine effects on an infectious pathogen. We also demonstrate the utility of empirical data in infectious disease modelling for high-burden, low-income settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the National Institutes of Health (NIH) grant number: R01 HD097175-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Manica Health Research Centre Internal Scientific Committee (CCI/03/2020), the Internal Ethical Review Board (initial approval CIBS-CISM/011/2020), the Emory University Institutional Review Board (approval number 00105630), and Yale University (reliance agreement approval number 2000026911).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
ar
